Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPV Boost in bOPV-Vaccinated Latin American Infants
NCT01831050Phase 4Completed
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- May 2013
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 4 trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started May 2013; status: completed.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT01831050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831050.